drugset / Trial / NCT07715149

A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic Function

NCT07715149

Phase 1 Recruiting 24 enrolled InventisBio Co., Ltd
Non-randomizedParallel-groupOpen-labelBasic science

Summary

This is a single-center, non-randomized, open-label, parallel-group study. It will test D-2570 in people with liver problems and in people with healthy livers, to see how the drug moves through the body and whether it is safe.

Timeline

Start
2026-07-14
Primary completion
2026-10-31
Completion
2026-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject D-2570 Unknown Oral

Indications

No indication recorded.